BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2022 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, April 28, 2022, inter alia, to approve and take on record the audited standalone and consolidated financial results for the quarter and year ended March 31, 2022 and to consider recommendation of dividend, if any, amongst other routine matters. The trading window for dealing in securities of the Company for all insiders, as defined under the Code of Conduct for Prevention of Insider Trading ('the Code') of the Company, has been closed from April 1, 2022 to April 30, 2022 (both days inclusive) in compliance with the provisions of the Code of the Company read with SEBI (Prohibition of Insider Trading) Regulations.